Perelman School Of Medicine University Of Pennsylvania
Bundled payments yield ‘modest’ savings from hip, knee replacement procedures
Hospitals that were enrolled in Medicare’s Bundled Payments for Care Improvement program saved about 2% for each major hip or knee replacement they performed compared with hospitals that were not enrolled in the program, data showed.
Dyslipidemia in pregnancy, ethics, genetics among key NLA topics
The virtual National Lipid Association Scientific Session, held Dec. 10 to 12, covered topics such as dyslipidemia during pregnancy, genetic testing and the ethical concerns of lipidologists.
Q&A: The importance of ‘high-quality targeted temperature management’ in post-arrest care
A new algorithm that includes targeted temperature management in post-cardiac arrest care was included in the 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
VIDEO: Modifying venetoclax dosing may help manage cytopenia in AML
Most patients with acute myeloid leukemia who responded to treatment with venetoclax plus azacitidine in the VIALE-A study required dosing modifications to manage cytopenia, according to a presentation from ASH Annual Meeting and Exposition.
VIDEO: Everolimus plus itacitinib well-tolerated in relapsed, refractory Hodgkin lymphoma
The combination of everolimus and itacitinib, an oral JAK inhibitor, was well-tolerated in patients with relapsed or refractory Hodgkin lymphoma, according to data presented at ASH Annual Meeting and Exposition.
VIDEO: FLT3 inhibitors appear superior to chemotherapy in FLT3-mutated AML
Gilteritinib and quizartinib were well-tolerated and linked to improved survival and treatment response compared with salvage chemotherapy for relapsed or refractory FLT3 internal tandem duplication-mutated acute myeloid leukemia.
VIDEO: Gilteritinib ‘remains active’ in AML patients who receive prior TKI therapy
Patients with relapsed or refractory acute myeloid leukemia who received prior tyrosine kinase inhibitor – midostaurin or sorafenib – achieved remission with gilteritinib, an FLT3 inhibitor, according to data presented at ASH Annual Meeting and Exposition.
Apremilast monotherapy effective in oligoarticular psoriatic arthritis
Treatment with apremilast alone is effective in patients with oligoarticular psoriatic arthritis, according to data published in The Journal of Rheumatology.
A decade of success: CAR-T pioneers reflect on past, look toward future
Inaugural class of FDA-AACR oncology educational fellows announced
American Association for Cancer Research announced the 2020-2021 class of FDA-AACR oncology educational fellows.